Climb Bio, Inc.
CLYM
$16.33
$1.6010.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.65M | 5.84M | 5.56M | 5.82M | 4.10M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.36M | 15.21M | 19.30M | 14.89M | 10.68M |
| Operating Income | -15.36M | -15.21M | -19.30M | -14.89M | -10.68M |
| Income Before Tax | -13.50M | -13.72M | -17.52M | -12.89M | -8.67M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.50M | -13.72M | -17.52M | -12.89M | -8.67M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.50M | -13.72M | -17.52M | -12.89M | -8.67M |
| EBIT | -15.36M | -15.21M | -19.30M | -14.89M | -10.68M |
| EBITDA | -15.33M | -15.17M | -19.27M | -14.86M | -10.66M |
| EPS Basic | -0.18 | -0.20 | -0.26 | -0.19 | -0.13 |
| Normalized Basic EPS | -0.11 | -0.13 | -0.16 | -0.12 | -0.08 |
| EPS Diluted | -0.18 | -0.20 | -0.26 | -0.19 | -0.13 |
| Normalized Diluted EPS | -0.11 | -0.13 | -0.16 | -0.12 | -0.08 |
| Average Basic Shares Outstanding | 76.15M | 68.21M | 67.37M | 68.00M | 67.59M |
| Average Diluted Shares Outstanding | 76.15M | 68.21M | 67.37M | 68.00M | 67.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |